These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7322696)

  • 41. Adverse effects of trimethoprim-sulfamethoxazole in a child with dihydropteridine reductase deficiency.
    Woody RC; Brewster MA
    Dev Med Child Neurol; 1990 Jul; 32(7):639-42. PubMed ID: 2391014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Measurement in samples of dry blood of dihydropteridine reductase and ratio of total biopterin in hyperphenylalaninemia and other neurological diseases].
    Leeming RJ; Karim AR; Sahota AS; Blair JA; Green A
    Arch Fr Pediatr; 1987; 44 Suppl 1():649-54. PubMed ID: 3449009
    [No Abstract]   [Full Text] [Related]  

  • 43. [Phenylketonuria due to dihydroptheridine reductase deficiency].
    Chopard A
    Pediatrie; 1977; 32(7):723-5. PubMed ID: 928039
    [No Abstract]   [Full Text] [Related]  

  • 44. Basal ganglion calcification in hyperphenylalaninemia due to deficiency of dihydropteridine reductase.
    Schmidt H; Ullrich K; Korinthenberg R; Peters PE
    Pediatr Radiol; 1988; 19(1):54-6. PubMed ID: 3222065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenylalanine has no effect on dihydropteridine reductase activity in phenylketonuria fibroblasts.
    Guttler F; Kaufman S; Milstien S
    Lancet; 1977 Nov; 2(8048):1139-40. PubMed ID: 73054
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pteridine reductase deficiency].
    Isshiki G
    Nihon Rinsho; 1978 May; Suppl():1338-9. PubMed ID: 691345
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hyperphenylalaninemia due to digydropteridine-reductase deficiency].
    Blehová B; Pazoutová N; Cerovská E; Jirásek J; Beránková M
    Cesk Pediatr; 1978 Jul; 33(7):404-5. PubMed ID: 699146
    [No Abstract]   [Full Text] [Related]  

  • 48. Purification of dihydropteridine reductase from human platelets.
    Shen R; Abell CW
    J Neurosci Res; 1981; 6(2):193-201. PubMed ID: 7241620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of antibodies to sheep liver dihydropteridine reductase: characterization and use to study the enzyme defect in a variant form of phenylketonuria.
    Milstien S; Kaufman S
    Biochem Biophys Res Commun; 1975 Sep; 66(2):475-81. PubMed ID: 810143
    [No Abstract]   [Full Text] [Related]  

  • 50. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
    Koslow SH; Butler IJ
    Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal determination of dihydropteridine reductase in a normal fetus at risk for malignant hyperphenylalaninemia.
    Firgaira FA; Cotton RG; Danks DM; Fowler K; Lipson A; Yu JS
    Prenat Diagn; 1983 Jan; 3(1):7-11. PubMed ID: 6844267
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of NADPH-specific dihydropteridine reductase in extract from human, monkey, and bovine livers by single radial immunodiffusion: selective assay differentiating NADPH- and NADH-specific enzymes.
    Nakanishi N; Ozawa K; Yamada S
    J Biochem; 1986 May; 99(5):1311-5. PubMed ID: 3086306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dihydropteridine reductase in schizophrenic patients.
    Szymanski HV; Orfanos A; Narisawa K; Grosz R; Naylor EW
    Psychiatry Res; 1985 Jun; 15(2):115-9. PubMed ID: 3862143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Dihydropteridine reductase: enzyme characteristics, regional distribution and ontogenetic development.
    Algeri S; Bonati M; Ponzio F; Turner AJ
    Br J Pharmacol; 1974 Nov; 52(3):448P. PubMed ID: 4156491
    [No Abstract]   [Full Text] [Related]  

  • 55. Cranial computerized tomography in dihydropteridine reductase deficiency.
    Longhi R; Valsasina R; Buttè C; Paccanelli S; Riva E; Giovannini M
    J Inherit Metab Dis; 1985; 8(3):109-12. PubMed ID: 2433499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis of dihydropteridine reductase deficiency.
    Smooker PM; Cotton RG
    Hum Mutat; 1995; 5(4):279-84. PubMed ID: 7627180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human dihydropteridine reductase: a method for the measurement of activity in cultured cells, and its application to malignant hyperphenylalaninemia.
    Firgaira FA; Cotton RG; Danks DM
    Clin Chim Acta; 1979 Jul; 95(1):47-59. PubMed ID: 41656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dihydropteridine reductase may function in tetrahydrofolate metabolism.
    Pollock RJ; Kaufman S
    J Neurochem; 1978 Jul; 31(1):115-23. PubMed ID: 209138
    [No Abstract]   [Full Text] [Related]  

  • 59. Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy.
    Woody RC; Brewster MA; Glasier C
    Neurology; 1989 May; 39(5):673-5. PubMed ID: 2785251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NADH-ferric reductase activity associated with dihydropteridine reductase.
    Lee PL; Halloran C; Cross AR; Beutler E
    Biochem Biophys Res Commun; 2000 May; 271(3):788-95. PubMed ID: 10814540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.